Differential inverse agonism at the human muscarinic M 3 receptor

Methods in Enzymology

Volumn 485, Issue C, 2010, Pages 81-101

  Casarosa, Paola ^a   Kiechle, Tobias ^a   Bakker, Remko A ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC M3 RECEPTOR;

BOOK; CELL POPULATION; CHO CELL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISSOCIATION; HUMAN; IRRITABLE COLON; MUSCLE FUNCTION; NONHUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SMOOTH MUSCLE;

EID: 78049523433     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381296-4.00005-1     Document Type: Chapter

References (32)

1. Azzi M., Charest P.G., Angers S., Rousseau G., Kohout T., Bouvier M., Pineyro G. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 2003, 100:11406-11411.
2. Bakker R.A., Wieland K., Timmerman H., Leurs R. Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists. Eur. J. Pharmacol. 2000, 387:R5-R7.
3. Barnes P.J. The role of anticholinergics in chronic obstructive pulmonary disease. Am. J. Med. 2004, 117(Suppl. 12A):24S-32S.
4. Burstein E.S., Spalding T.A., Brauner-Osborne H., Brann M.R. Constitutive activation of muscarinic receptors by the G-protein Gq. FEBS Lett. 1995, 363:261-263.
5. Casarosa P., Bakker R.A., Verzijl D., Navis M., Timmerman H., Leurs R., Smit M.J. Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J. Biol. Chem. 2001, 276:1133-1137.
6. Casarosa P., Bouyssou T., Germeyer S., Schnapp A., Gantner F., Pieper M. Preclinical evaluation of long-acting muscarinic antagonists: Comparison of tiotropium and investigational drugs. J. Pharmacol. Exp. Ther. 2009, 330:660-668.
7. Casarosa P., Kiechle T., Sieger P., Pieper M., Gantner F. The constitutive activity of the human muscarinic M3 receptor unmasks differences in the pharmacology of anticholinergics. J. Pharmacol. Exp. Ther. 2010, 333:201-209.
8. Cheng K., Samimi R., Xie G., Shant J., Drachenberg C., Wade M., Davis R.J., Nomikos G., Raufman J.P. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G591-G597.
9. Chevalier B., Mansier P., Teiger E., Callen-el A.F., Swynghedauw B. Alterations in beta adrenergic and muscarinic receptors in aged rat heart. Effects of chronic administration of propranolol and atropine. Mech. Ageing Dev. 1991, 60:215-224.
10. Chiba Y., Murata M., Ushikubo H., Yoshikawa Y., Saitoh A., Sakai H., Kamei J., Misawa M. Effect of cigarette smoke exposure in vivo on bronchial smooth muscle contractility in vitro in rats. Am. J. Respir Cell Mol. Biol. 2005, 33:574-581.
11. Disse B., Speck G.A., Rominger K.L., Witek T.J., Hammer R. Tiotropium (Spiriva): Mechanistical considerations and clinical profile in obstructive lung disease. Life Sci. 1999, 64:457-464.
12. Dowling M.R., Willets J.M., Budd D.C., Charlton S.J., Nahorski S.R., Challiss R.A. A single point mutation (N514Y) in the human M3 muscarinic acetylcholine receptor reveals differences in the properties of antagonists: Evidence for differential inverse agonism. J. Pharmacol. Exp. Ther. 2006, 317:1134-1142.
13. Fernandez-Rodriguez S., Broadley K.J., Ford W.R., Kidd E.J. Increased muscarinic receptor activity of airway smooth muscle isolated from a mouse model of allergic asthma. Pulm. Pharmacol. Ther. 2010, 23:300-307.
14. Gandevia B. Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders. Postgrad. Med. J. 1975, 51:13-20.
15. Ghanouni P., Gryczynski Z., Steenhuis J.J., Lee T.W., Farrens D.L., Lakowicz J.R., Kobilka B.K. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. J. Biol. Chem. 2001, 276:24433-24436.
16. Hotta K., Emala C.W., Hirshman C.A. TNF-alpha upregulates Gialpha and Gqalpha protein expression and function in human airway smooth muscle cells. Am. J. Physiol 1999, 276:L405-L411.
17. Jakubik J., Bacakova L., El-Fakahany E.E., Tucek S. Constitutive activity of the M1-M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists. FEBS Lett. 1995, 377:275-279.
18. Johnson E.N., Druey K.M. Heterotrimeric G protein signaling: Role in asthma and allergic inflammation. J. Allergy Clin. Immunol. 2002, 109:592-602.
19. Kenakin T. Ligand-selective receptor conformations revisited: The promise and the problem. Trends Pharmacol. Sci. 2003, 24:346-354.
20. Kummer W., Lips K.S., Pfeil U. The epithelial cholinergic system of the airways. Histochem. Cell Biol. 2008, 130:219-234.
21. Milligan G., Bond R.A. Inverse agonism and the regulation of receptor number. Trends Pharmacol. Sci. 1997, 18:468-474.
22. Peretto I., Petrillo P., Imbimbo B.P. Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists. Med. Res. Rev. 2009, 29:867-902.
23. Profita M., Giorgi R.D., Sala A., Bonanno A., Riccobono L., Mirabella F., Gjomarkaj M., Bonsignore G., Bousquet J., Vignola A.M. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005, 60:1361-1369.
24. Profita M., Bonanno A., Siena L., Bruno A., Ferraro M., Montalbano A.M., Albano G.D., Riccobono L., Casarosa P., Pieper M.P., Gjomarkaj M. Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease. J. Pharmacol. Exp. Ther. 2009, 329:753-763.
25. Shah N., Khurana S., Cheng K., Raufman J.P. Muscarinic receptors and ligands in cancer. Am. J. Physiol. Cell Physiol. 2009, 296:C221-C232.
26. Tashkin D.P., Celli B., Senn S., Burkhart D., Kesten S., Menjoge S., Decramer M. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 2008, 359:1543-1554.
27. Vesely P.W., Staber P.B., Hoefler G., Kenner L. Translational regulation mechanisms of AP-1 proteins. Mutat. Res. 2009, 682:7-12.
28. Vincken W., Van Noord J.A., Greefhorst A.P., Bantje T.A., Kesten S., Korducki L., Cornelissen P.J. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur. Respir. J. 2002, 19:209-216.
29. Wall S.J., Yasuda R.P., Li M., Ciesla W., Wolfe B.B. Differential regulation of subtypes m1-m5 of muscarinic receptors in forebrain by chronic atropine administration. J. Pharmacol. Exp. Ther. 1992, 262:584-588.
30. Wess J., Eglen R.M., Gautam D. Muscarinic acetylcholine receptors: Mutant mice provide new insights for drug development. Nat. Rev. Drug Discov. 2007, 6:721-733.
31. Witt-Enderby P.A., Yamamura H.I., Halonen M., Lai J., Palmer J.D., Bloom J.W. Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment. Mol. Pharmacol. 1995, 47:485-490.
32. Zeng F.Y., McLean A.J., Milligan G., Lerner M., Chalmers D.T., Behan D.P. Ligand specific up-regulation of a Renilla reniformis luciferase-tagged, structurally unstable muscarinic M3 chimeric G protein-coupled receptor. Mol. Pharmacol. 2003, 64:1474-1484.